PDIA3 and hepatocellular carcinoma: In vitro studies have revealed that knockdown of ERp57 inhibits HCC cell proliferation 92 and enhances the paclitaxel sensitivity of paclitaxel‐resistant SKOV3/tax cells by blocking the STAT3 pathway 5.